share_log

Percheron Therapeutics Ltd: Phase IIb study of ATL1102 in DMD completes recruitment

May 29 07:01
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.